|
Volumn 7, Issue 4, 2008, Pages 349-356
|
Current trends in malarial chemotherapy
|
Author keywords
Artemisinine; Chemotherapy; Combination therapy; Malaria; Resistance
|
Indexed keywords
AMODIAQUINE;
ANTIBIOTIC AGENT;
ANTIMALARIAL AGENT;
ARTEETHER;
ARTELINIC ACID;
ARTEMETHER;
ARTEMETHER PLUS BENFLUMETOL;
ARTEMISININ;
ARTEMISININ DERIVATIVE;
ARTESUNATE;
ATOVAQUONE;
ATOVAQUONE PLUS PROGUANIL;
CHLOROQUINE;
CHLORPROGUANIL PLUS DAPSONE;
CLINDAMYCIN;
CLINDAMYCIN PLUS FOSMIDOMYCIN;
DIHYDROARTEMISININ;
DIHYDROARTEMISININ PLUS PIPERAQUINE;
FOSMIDOMYCIN;
HALOFANTRINE;
MALARIA VACCINE;
MEFLOQUINE;
PRIMAQUINE;
PROGUANIL;
PYRIMETHAMINE;
QUININE;
SULFALENE;
SULFONAMIDE;
TRIMETHOPRIM;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANEMIA;
ANOREXIA;
ANTIBIOTIC RESISTANCE;
CONVULSION;
DRUG CLASSIFICATION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG METABOLISM;
FEVER;
GAMETOCYTE;
HUMAN;
LIFE CYCLE;
MALARIA;
MOSQUITO;
NONHUMAN;
PARASITE TRANSMISSION;
PLASMODIUM;
PLASMODIUM FALCIPARUM;
PLASMODIUM OVALE;
PLASMODIUM VIVAX;
REVIEW;
SCHIZONT;
SPOROCYST;
TREATMENT OUTCOME;
WEAKNESS;
ARTESUNATE;
|
EID: 40449085698
PISSN: None
EISSN: 16845315
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (20)
|
References (33)
|